Details
Open$8.43
$8.43
The price of this investment when the exchange last opened.
High$8.53
$8.53
The highest price of this investment during regular trading hours.
Low$7.92
$7.92
The lowest price of this investment during regular trading hours.
Mkt cap928M
928M
The value of this ETF or company's issued shares based on the price of a single share multiplied by the total number of issued shares.
P/E ratio
The price to earnings ratio (P/E) is the relationship between an investment's price and earnings per share (EPS). It's a metric that can be used to determine the valuation or potential growth of an investment based on its past or future earnings. It's calculated by dividing the share price by EPS.
52-wk high$46.25
$46.25
The highest price this investment has been in the past 52 weeks.
52-wk low$2.43
$2.43
The lowest price this investment has been in the past 52 weeks.
Volume7.69M
7.69M
The total number of shares bought and sold.
EPS (TTM)-4.60
-4.60
Earnings per share (EPS) is the amount of profit a company generated for each outstanding share of its common stock. It is often used as an indicator of company profitability.
About TLRY
Tilray, Inc. engages in the research, cultivation, production, and distribution of medical cannabis and cannabinoids. The Company is focused on medical cannabis research, cultivation, processing and distribution of cannabis products worldwide. Its products include dried cannabis and cannabis extracts. It operates through the following segments: Cannabis and Hemp. The Cannabis segment sales consists of adult-use, medical and bulk sales of cannabis under regulated licenses and sold to retail, wholesale, pharmacy, government, and direct to patient. The Hemp segment sales consist of hemp seed, hemp foods, board spectrum hemp extract containing CBD which are sold in an unlicensed operation and sold to retail, wholesale and direct to consumers. The company was founded on January 24, 2018 and is headquartered in Nanaimo, Canada.
CEO
Brendan Kennedy, MBA
Headquarters
Canada
Employees
1.65K
Revenue (TTM)
196M
Gross Profit
19.16%
Earnings
-364.64%
Cash
$174M
Debt
$509M
